Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size


 
Table of Contents   
LETTER TO THE EDITOR
Year : 2012  |  Volume : 7  |  Issue : 3  |  Page : 171
Serum hepcidin and chronic obstructive pulmonary disease


1 Sanitation, Medical Academic Center, Bangkok, Thailand
2 Wiwanitkit House, Bangkhae, Bangkok, Thailand

Date of Web Publication21-Jul-2012

Correspondence Address:
Beuy Joob
Sanitation, Medical Academic Center, Bangkok
Thailand
Login to access the Email id


DOI: 10.4103/1817-1737.98855

Rights and Permissions



How to cite this article:
Joob B, Wiwanitkit V. Serum hepcidin and chronic obstructive pulmonary disease. Ann Thorac Med 2012;7:171

How to cite this URL:
Joob B, Wiwanitkit V. Serum hepcidin and chronic obstructive pulmonary disease. Ann Thorac Med [serial online] 2012 [cited 2019 Oct 18];7:171. Available from: http://www.thoracicmedicine.org/text.asp?2012/7/3/171/98855


Sir,

The recent report on serum hepcidin and COPD is very interesting. [1] Duru et al. concluded that "serum hepcidin level may be a useful marker in COPD." [1] As Duru et al. proposed, a further confirmation is required. An important point is there is no complete assessment on hepatitis profile (such as hepatitis B, hepatitis C, etc.) needed. Also, some genetic disorders can also alter the hepcidin level that has to be ruled out. Thalassemia [2] as well as some other rare genetic mutations [3] should be ruled out. It is still very inconclusive to conclude for any usefulness of hepcidin as a new biomarker for COPD.

 
   References Top

1.Duru S, Bilgin E, Ardiç S. Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med 2012;7:31-5.  Back to cited text no. 1
    
2.Origa R, Galanello R. Pathophysiology of beta thalassaemia. Pediatr Endocrinol Rev 2011;8 (Suppl 2):263-70.  Back to cited text no. 2
[PUBMED]    
3.Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008;93:1473-9.  Back to cited text no. 3
[PUBMED]    



This article has been cited by
1 Authorsę reply
ArdiƧ, S.
Annals of Thoracic Medicine. 2012; 7(3): 171-172
[Pubmed]



 

Top
Print this article  Email this article
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (223 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1620    
    Printed63    
    Emailed0    
    PDF Downloaded321    
    Comments [Add]    
    Cited by others 1    

Recommend this journal